[HTML][HTML] Predicting Resistance to Immunotherapy in Melanoma, Glioblastoma, Renal, Stomach and Bladder Cancers by Machine Learning on Immune Profiles
Simple Summary This study addresses the limitations of immune checkpoint inhibitors
(ICBs) in cancer therapy, where over 38% of patients show resistance and disease …
(ICBs) in cancer therapy, where over 38% of patients show resistance and disease …
[HTML][HTML] Leveraging Tumor Mutation Profiles to Forecast Immune Checkpoint Blockade Resistance in Melanoma, Lung, Head and Neck, Bladder and Renal Cancers
Immune checkpoint blockade (ICB), radiotherapy, chemotherapy and surgery are currently
used as therapeutic strategies against melanoma, lung, bladder and renal cancers, but their …
used as therapeutic strategies against melanoma, lung, bladder and renal cancers, but their …
[HTML][HTML] Fraction of Genome Altered, Age, Microsatellite Instability Score, Tumor Mutational Burden, Cancer Type, Metastasis Status, and Choice of Cancer Therapy …
Abstract Background/Objectives: The accurate prediction of overall survival (OS) in cancer
patients is crucial for personalized treatment strategies. Methods: In this study, we …
patients is crucial for personalized treatment strategies. Methods: In this study, we …